Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.
UroGen Pharma Ltd. net margin for the quarter ending 2026-06-30 was -19.81%, a change of 186.43% year-over-year.
UroGen Pharma Ltd. net margin for the quarter ending 2026-03-31 was -46.26%, a change of 170.21% year-over-year.
UroGen Pharma Ltd. net margin for the quarter ending 2025-12-31 was -69.68%, a change of 83.03% year-over-year.
UroGen Pharma Ltd. net margin for the quarter ending 2025-09-30 was -121.34%, a change of -27.42% year-over-year.
UroGen Pharma Ltd. net margin for fiscal 2025 was -139.81%, a change of 0.54% from fiscal 2024.
UroGen Pharma Ltd. net margin for fiscal 2024 was -140.35%, a change of -16.74% from fiscal 2023.
UroGen Pharma Ltd. net margin for fiscal 2023 was -123.61%, a change of 46.97% from fiscal 2022.
UroGen Pharma Ltd. net margin for fiscal 2022 was -170.58%, a change of 60.09% from fiscal 2021.